SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-007341
Filing Date
2023-03-13
Accepted
2023-03-13 07:00:35
Documents
12
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33052
  Complete submission text file 0001493152-23-007341.txt   206302

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20230313.xsd EX-101.SCH 3257
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20230313_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20230313_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 23725656
SIC: 2834 Pharmaceutical Preparations